Đánh giá đa thông số MRI của các sarcoma xương ở trẻ em

WHO Classification of Tumours Editorial Board (2020) Soft tissue and bone tumours. International Agency for Research on Cancer Press, Lyon, France Kaste SC (2011) Imaging pediatric bone sarcomas. Radiol Clin North Am 49:749–765 McCarville MB, Chen JY, Coleman JL et al (2015) Distinguishing osteomyelitis from Ewing sarcoma on radiography and MRI. AJR Am J Roentgenol 205:640–650 Wang CS, Yin QH, Liao JS et al (2012) Primary diaphyseal osteosarcoma in long bones: imaging features and tumor characteristics. Eur J Radiol 81:3397–3403 Alsharief AN, Martinez-Rios C, Hopyan S, Amirabadi A, Doria AS, Greer MLC (2019) Usefulness of diffusion-weighted MRI in the initial assessment of osseous sarcomas in children and adolescents. Pediatr Radiol 49:1201–1208 Thompson MJ, Shapton JC, Punt SE, Johnson CN, Conrad EU 3rd (2018) MRI identification of the osseous extent of pediatric bone sarcomas. Clin Orthop Relat Res 476:559–564 Casali PG, Bielack S, Abecassis N et al (2018) Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 29:iv79–iv95 Guenther LM, Rowe RG, Acharya PT et al (2018) Response Evaluation Criteria in Solid Tumors (RECIST) following neoadjuvant chemotherapy in osteosarcoma. Pediatr Blood Cancer 65(4) McCarville MB, Federico SM, Bishop MW et al (2016) Assessment of chemotherapy response in ewing sarcoma. Radiology 281(2):647–649 Saifuddin A, Sharif B, Gerrand C, Whelan J (2019) The current status of MRI in the pre-operative assessment of intramedullary conventional appendicular osteosarcoma. Skeletal Radiol 48(4):503–516 Masrouha KZ, Musallam KM, Samra AB et al (2012) Correlation of non-mass-like abnormal MR signal intensity with pathological findings surrounding pediatric osteosarcoma and Ewing’s sarcoma. Skeletal Radiol 41:1453–1461 Murphey MD, Senchak LT, Mambalam PK, Logie CI, Klassen-Fischer MK, Kransdorf MJ (2013) From the radiologic pathology archives: Ewing sarcoma family of tumors: radiologic-pathologic correlation. Radiographics 33:803–831 Neubauer H, Evangelista L, Hassold N et al (2012) Diffusion-weighted MRI for detection and differentiation of musculoskeletal tumorous and tumor-like lesions in pediatric patients. World J Pediatr 8:342–349 Subhawong TK, Wilky BA (2015) Value added: functional MR imaging in management of bone and soft tissue sarcomas. Curr Opin Oncol 27:323–331 Degnan AJ, Chung CY, Shah AJ et al (2018) Quantitative diffusion-weighted magnetic resonance imaging assessment of chemotherapy treatment response of pediatric osteosarcoma and Ewing sarcoma malignant bone tumors. Clin Imaging 47:9–13 Pullens P, Bladt P, Sijbers J et al (2017) Technical Note: A safe, cheap, and easy-to-use isotropic diffusion MRI phantom for clinical and multicenter studies. Med Phys 44(3):1063–1070 Hori M, Kamiya K, Murata K (2021) Technical basics of diffusion-weighted imaging. Magn Reson Imaging Clin N Am 29(2):129–136 Asmar K, Saade C, Salman R et al (2020) The value of diffusion weighted imaging and apparent diffusion coefficient in primary osteogenic and Ewing sarcomas for the monitoring of response to treatment: initial experience. Eur J Radiol 28(124):108855 Subhawong TK, Jacobs MA, Fayad LM (2014) Diffusion-weighted MR imaging for characterizing musculoskeletal lesions. Radiographics 34:1163–1177 Surov A, Nagata S, Razek AA, Tirumani SH, Wienke A, Kahn T (2015) Comparison of ADC values in different malignancies of the skeletal musculature: a multicentric analysis. Skeletal Radiol 44:995–1000 Hayashida Y, Yakushiji T, Awai K et al (2006) Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results. Eur Radiol 16:2637–2643 Saleh MM, Abdelrahman TM, Madney Y, Mohamed G, Shokry AM, Moustafa AF (2020) Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing’s sarcoma. Br J Radiol 93(1115):20200257 Oka K, Yakushiji T, Sato H, Hirai T, Yamashita Y, Mizuta H (2010) The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient. Skeletal Radiol 39:141–146 Nakajo M, Fukukura Y, Hakamada H et al (2018) Whole-tumor apparent diffusion coefficient (ADC) histogram analysis to differentiate benign peripheral neurogenic tumors from soft tissue sarcomas. Magn Reson Imaging 48:680–686 Singer AD, Pattany PM, Fayad LM, Tresley J, Subhawong TK (2016) Volumetric segmentation of ADC maps and utility of standard deviation as measure of tumor heterogeneity in soft tissue tumors. Clin Imaging 40:386–391 Kubo T, Furuta T, Johan MP, Ochi M, Adachi N (2017) Value of diffusion-weighted imaging for evaluating chemotherapy response in osteosarcoma: a meta-analysis. Mol Clin Oncol 7:88–92 Lee SK, Jee WH, Jung CK, Im SA, Chung NG, Chung YG (2020) Prediction of poor responders to neoadjuvant chemotherapy in patients with osteosarcoma: additive value of diffusion-weighted MRI including volumetric analysis to standard MRI at 3T. PLoS One 10;15(3):e0229983. Baidya Kayal E, Kandasamy D, Khare K, Bakhshi S, Sharma R, Mehndiratta A (2019) Intravoxel incoherent motion (IVIM) for response assessment in patients with osteosarcoma undergoing neoadjuvant chemotherapy. Eur J Radiol 119:108635 Fayad LM, Mugera C, Soldatos T, Flammang A, del Grande F (2013) Technical innovation in dynamic contrast-enhanced magnetic resonance imaging of musculoskeletal tumors: an MR angiographic sequence using a sparse k-space sampling strategy. Skeletal Radiol 42:993–1000 Costa FM, Martins PH, Canella C, Lopes FPPL (2018) Multiparametric MR imaging of soft tissue tumors and pseudotumors. Magn Reson Imaging Clin N Am 26:543–558 Kubo T, Furuta T, Johan MP et al (2016) Percent slope analysis of dynamic magnetic resonance imaging for assessment of chemotherapy response of osteosarcoma or Ewing sarcoma: systematic review and meta-analysis. Skeletal Radiol 45(9):1235–1242 Dyke JP, Panicek DM, Healey JH et al (2003) Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging. Radiology 228(1):271–278 Fayad LM, Jacobs MA, Wang X, Carrino JA, Bluemke DA (2012) Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques. Radiology 265:340–356 Guo J, Reddick WE, Glass JO et al (2012) Dynamic contrast-enhanced magnetic resonance imaging as a prognostic factor in predicting event-free and overall survival in pediatric patients with osteosarcoma. Cancer 118:3776–3785 Van Rijswijk CS, Geirnaerdt MJ, Hogendoorn PC (2004) Soft-tissue tumors: value of static and dynamic gadopentetatedimeglumine-enhanced MR imaging in prediction of malignancy. Radiology 233:493–502 Lavini C, de Jonge MC, van de Sande MGH et al (2007) Pixel-by-pixel analysis of DCE MRI curve patterns and an illustration of its application to the imaging of the musculoskeletal system. Magn Reson Imaging 25(5):604–612 Vilanova JC, Baleato-Gonzalez S, Romero M, Carrascoso-Arranz J, Luna A (2016) Assessment of musculoskeletal malignancies with functional MR imaging. Magn Reson Imaging Clin N Am 24:239–259 Choyke PL, Dwyer AJ, Knopp MV (2003) Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Imaging 17:509–520 Uhl M, Saueressig U, van Buiren M et al (2006) Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging. Invest Radiol 41(8):618–623 Longhi A, Errani C, Paolis De, Mercuri M, Bacci G (2006) Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 32:423–436 Lindsey BA, Markel JE, Kleinerman ES (2017) Osteosarcoma overview. Rheumatol Ther 4:25–43 Vijayakumar V, Lowery R, Zhang X et al (2014) Pediatric osteosarcoma: a single institution’s experience. South Med J 107:671–675 Wang CS, Du LJ, Si MJ et al (2013) Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted i. PLoS One 8:e72679 Zeitoun R, Shokry AM, Ahmed Khaleel S, Mogahed SM (2018) Osteosarcoma subtypes: magnetic resonance and quantitative diffusion weighted imaging criteria. J Egypt Natl Canc Inst 30:39–44 Wang J, Sun M, Liu D et al (2017) Correlation between apparent diffusion coefficient and histopathology subtypes of osteosarcoma after neoadjuvant chemotherapy. Acta Radiol 58:971–976 Zishan US, Pressney I, Khoo M, Saifuddin A (2020) The differentiation between aneurysmal bone cyst and telangiectaticosteosarcoma: a clinical, radiographic and MRI study. Skeletal Radiol 49(9):1375–1386 Lahl M, Fisher VL, Laschinger K (2008) Ewing’s sarcoma family of tumors: an overview from diagnosis to survivorship. Clin J Oncol Nurs 12:89–97 Murphey MD, Kransdorf MJ (2021) Staging and classification of primary musculoskeletal bone and soft-tissue tumors according to the 2020 WHO update, from the AJR Special Series on Cancer Staging. AJR Am J Roentgenol 217(5):1038–1052 Parlak S, Ergen FB, Yüksel GY et al (2021) Diffusion-weighted imaging for the differentiation of Ewing sarcoma from osteosarcoma. Skeletal Radiol 50(10):2023–2030 Habre C, Dabadie A, Loundou AD et al (2021) Diffusion-weighted imaging in differentiating mid-course responders to chemotherapy for long-bone osteosarcoma compared to the histologic response: an update. Pediatr Radiol 51(9):1714–1723 Huang B, Wang J, Sun M et al (2020) Feasibility of multi-parametric magnetic resonance imaging combined with machine learning in the assessment of necrosis of osteosarcoma after neoadjuvant chemotherapy: a preliminary study. BMC Cancer 20(1):322